In case you missed it: January 16 to January 20
Take a look back at this week's top stories.
Is this a case of negligence?
By Hindi Stohl, MD, JD, James M. Shwayder, MD, JD
This month's Legally Speaking column delves into a case regarding shoulder and abdominal dystocia during a vaginal delivery for fetal hydrops.
Alabama attorney general steps back on abortion pill prosecution statement
By Lindsey Carr, Editor
Alabama’s attorney general retracted comments he made last week suggesting criminal prosecution for women taking abortion pills for pregnancy termination. He is now saying that only providers who prescribe the pills could be prosecuted.
Daré Bioscience announces positive data on intravaginal ring for vasomotor and vaginal menopause symptoms
By Lindsey Carr, Editor
If approved, DARE-HRT1 would become the first FDA-approved monthly intravaginal ring to deliver both estrogen and progestin hormone therapy.
Impact of cannabis legalization on prenatal marijuana use
By Lindsey Carr, Editor
Findings from a study in JAMA Network Open reveal valuable insight into the way cannabis legalization has impacted the perceptions of pregnant women who use cannabis in the US.
Eating disorders can develop at any age, including perimenopause
By Lindsey Carr, Editor
A new study in Menopause found body dissatisfaction to be a primary cause of eating disorders, especially during perimenopause.
Opioid use disorder and contraception
By John Jesitus
Women on Medicaid with opioid use disorder (OUD) who use medications for opioid use disorder (MOUD) are more likely to use contraception and to undergo female sterilization than peers not prescribed MOUD, according to a study in Contraception.
Artificial insemination outcomes not impacted by COVID-19 vaccination status
By Lindsey Carr, Editor
The findings indicate a previously confirmed notion that COVID-19 vaccination does not impact pregnancy outcomes in couples experiencing infertility.
See you next week!